Investigational Site Number : 1560002

Pingxiang 337055

1 studies enrolling now · 2 studies all time

What they study most

Asthma

Studies at this site

• Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma — Enrolling by invitation
• Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma — Completed